Bank of New York Mellon’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.85M | Buy |
|
|||||
|
2025
Q2 | $2.24M | Buy |
|
|||||
|
2025
Q1 | $948K | Sell |
|
|||||
|
2024
Q4 | $945K | Buy |
|
|||||
|
2024
Q3 | $620K | Sell |
|
|||||
|
2024
Q2 | $617K | Buy |
|
|||||
|
2024
Q1 | $34.3K | Sell |
|
|||||
|
2023
Q4 | $89.1K | Buy |
|
|||||
|
2023
Q3 | $81.9K | Sell |
|
|||||
|
2023
Q2 | $65.7K | Hold |
|
|||||
|
2023
Q1 | $40.3K | Hold |
|
|||||
|
2022
Q4 | $41.4K | Hold |
|
|||||
|
2022
Q3 | $23K | Hold |
|
|||||
|
2022
Q2 | $26K | Sell |
|
|||||
|
2022
Q1 | $459K | Buy |
|
|||||
|
2021
Q4 | $1.41M | Buy |
|
|||||
|
2021
Q3 | $1.7M | Buy |
|
|||||
|
2021
Q2 | $2.13M | Sell |
|
|||||
|
2021
Q1 | $2.02M | Sell |
|
|||||
|
2020
Q4 | $1.84M | Buy |
|
|||||
|
2020
Q3 | $1.45M | Sell |
|
|||||
|
2020
Q2 | $8.57M | Buy |
|
|||||
|
2020
Q1 | $4.48M | Sell |
|
|||||
|
2019
Q4 | $4.38M | Buy |
|
|||||
|
2019
Q3 | $2.62M | Sell |
|
|||||
|
2019
Q2 | $3.26M | Buy |
|
|||||
|
2019
Q1 | $4.54M | Buy |
|
|||||
|
2018
Q4 | $3.03M | Buy |
|
|||||
|
2018
Q3 | $1.9M | Buy |
|
|||||
|
2018
Q2 | $2.14M | Buy |
|
|||||
|
2018
Q1 | $1.91M | Sell |
|
|||||
|
2017
Q4 | $3.74M | Buy |
|
|||||
|
2017
Q3 | $4.41M | Buy |
|
|||||
|
2017
Q2 | $2.87M | Buy |
|
|||||
|
2017
Q1 | $1.35M | Sell |
|
|||||
|
2016
Q4 | $1.54M | Buy |
|
|||||
|
2016
Q3 | $1.15M | Sell |
|
|||||
|
2016
Q2 | $971K | Buy |
|
|||||
|
2016
Q1 | $1.08M | Sell |
|
|||||
|
2015
Q4 | $1.93M | Buy |
|
|||||
|
2015
Q3 | $1.41M | Buy |
|
|||||
|
2015
Q2 | $736K | Buy |
|
|||||
|
2015
Q1 | $388K | Sell |
|
|||||
|
2014
Q4 | $406K | Buy |
|
|||||
|
2014
Q3 | $665K | Buy |
|
|||||
|
2014
Q2 | $795K | Buy |
|